Up a level |
Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, DJ, Rannard, S ORCID: 0000-0002-6946-1097, Meyers, CF, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2018)
In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents.
Clinical pharmacokinetics, 57 (02).
pp. 255-266.
Swindells, S, Siccardi, M ORCID: 0000-0002-3539-7867, Barrett, SE, Olsen, DB, Grobler, JA, Podany, AT, Nuermberger, E, Kim, P, III, Barry CE, Owen, A ORCID: 0000-0002-9819-7651 et al (show 2 more authors)
(2018)
Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (2).
pp. 125-132.
Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2016)
Long-acting injectable formulations for children and adolescents using PBPK modelling.
11 August 2016, Swansea.
Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, AT, Moss, DM, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2018)
Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (8).
pp. 937-944.
Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, A, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2016)
Simulation of long-acting administration of antituberculosis agents using pharmacokinetic modelling.
24 October 2016, Liverpool.
Rajoli, RKR ORCID: 0000-0002-6015-5712, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651, Donnelly, R and Siccardi, M ORCID: 0000-0002-3539-7867
(2017)
Transdermal delivery with microneedle patches using in silico modelling.
10 August 2017, Belfast.